Cargando…
S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION
Autores principales: | Guolo, Fabio, Minetto, Paola, Pesce, Silvia, Ballerini, Filippo, Cea, Michele, Greppi, Marco, Bozzo, Matteo, Miglino, Maurizio, Tedone, Elisabetta, Bo, Alessandra, Serio, Alberto, Luchetti, Silvia, Candiani, Simona, Mora, Marco, Agostini, Vanessa, Nozza, Paolo, Del Zotto, Genny, Marcenaro, Emanuela, Lemoli, Roberto Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428396/ http://dx.doi.org/10.1097/01.HS9.0000967780.46838.75 |
Ejemplares similares
-
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
por: Guolo, Fabio, et al.
Publicado: (2021) -
Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019) -
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
por: Pesce, Silvia, et al.
Publicado: (2020) -
Harnessing Immune Response in Acute Myeloid Leukemia
por: Riva, Carola, et al.
Publicado: (2023) -
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
por: Pesce, Silvia, et al.
Publicado: (2019)